US20030200727A1 - Collection assembly - Google Patents

Collection assembly Download PDF

Info

Publication number
US20030200727A1
US20030200727A1 US10/271,107 US27110702A US2003200727A1 US 20030200727 A1 US20030200727 A1 US 20030200727A1 US 27110702 A US27110702 A US 27110702A US 2003200727 A1 US2003200727 A1 US 2003200727A1
Authority
US
United States
Prior art keywords
container
liquid
film
open top
packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/271,107
Inventor
Yong Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Priority to US10/271,107 priority Critical patent/US20030200727A1/en
Assigned to BECTON, DICKINSON AND COMPANY reassignment BECTON, DICKINSON AND COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KIM, YONG JAE
Publication of US20030200727A1 publication Critical patent/US20030200727A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/505Containers for the purpose of retaining a material to be analysed, e.g. test tubes flexible containers not provided for above
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D77/00Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
    • B65D77/003Articles enclosed in rigid or semi-rigid containers, the whole being wrapped
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/142Preventing evaporation

Definitions

  • the subject invention relates to plastic tubes that have been prefilled with controlled volumes and concentrations of liquid, and that are packaged to retain the liquid volume and concentration during storage.
  • Some drugs can be stored for considerable periods of time in a liquid form. Other drugs, however, must be stored in a powdered form, and then must be mixed with a specified volume of a liquid additive shortly prior to administration to the patient. Efficiencies can be achieved if the specified volume of the liquid drug and/or the specified volume of the liquid additive is available in a prefilled tube or other such container. Prefilled containers avoid the need for careful volummetric measuring immediately prior to administering the drug, and hence minimize the chance for error.
  • Plastic tubes and other plastic containers are lightweight, relatively inexpensive and relatively unbreakable. As a result, plastic tubes are used for medical applications whenever possible. However, plastic tubes have an inherent permeability to water and other liquids. This high liquid permeability of plastics can significantly affect the volume, concentration and solubility of liquids that are stored for a long period of time in a plastic container. Containers filled with a liquid drug or with a liquid additive for a powdered drug desirably should have a relatively long shelf life. As a result, plastic containers are considered unacceptable for long term storage of liquid drugs or liquid additives for drugs.
  • Glass is substantially impermeable to water and other liquids.
  • liquid drugs or liquid additives for drugs typically are stored in glass tubes or other glass containers.
  • glass is much more breakable than plastic.
  • a glass tube can be broken easily while the tube is being manipulated to access the liquid stored therein.
  • a small round glass tube can be dropped inadvertently and shattered inadvertently. Sharp edges of a broken glass tube can cut a patient or health care worker, and may create an open wound that can lead to disease transmission.
  • Fragile glass containers also require protective packaging that typically increases storage space requirements and that may add to costs.
  • the prior art has included attempts to minimize or offset the loss of liquid from plastic tubes.
  • one prior art attempt has bulk packaged a plurality of plastic tubes in a plastic tub.
  • a moisture source also has been placed in the tub to provide a higher vapor content surrounding the bulk packaged tubes, and thereby to impede the outflow of liquid from the tubes.
  • This prior art bulk packaging complicates the packaging process and adds to cost and storage space requirements.
  • vapor from the moisture source is transported through the permeable walls of the plastic tub.
  • the prior art also includes tubes that are laminated with foil to prevent liquid loss. Foil lamination of tubes adds significantly to the tube manufacturing complexity and adds to tube manufacturing cost.
  • the subject invention is directed to a plastic container in which a liquid drug or a liquid additive solution for a drug has been placed.
  • the plastic container may be formed from a known plastic material, such as polyethylene terephthalate (PET), polypropylene or other plastic material that exhibits liquid permeability.
  • PET polyethylene terephthalate
  • the container may be a tube of prior art construction, and may include a closed bottom, an open top and a continuous side wall extending therebetween.
  • a closure may be securely mounted to the container for closing the open top, and thereby preventing spillage of the liquid drug or the liquid additive stored in the container.
  • the subject invention further includes packaging formed from a high moisture barrier material that completely surrounds the container or that completely surrounds a plurality of such containers.
  • the high moisture barrier material may be a film formed from a foil lamination, a metalized polyester, SiOx coated polyesters, polyester-polyoefilins, PVDC or the like.
  • This high moisture barrier material may be a sheet folded around one or more plastic containers of a liquid drug or liquid additive. Edge regions of the sheet then may be sealed in face-to-face engagement with other areas on the sheet. Alternatively a container may be placed between two sheets of high moisture barrier material, and edge regions of the sheets may be sealed.
  • the high moisture barrier packaging material can impede the rate of water vapor transport across the plastic material from which the container is formed by providing and maintaining a high relative humidity environment around the container and inside the package. This enables the volume, concentration and solubility of the liquid in the container to be controlled, and enables a longer shelf life for the liquid therein.
  • FIG. 1 is a top plan view of a liquid-containing plastic tube packaged in accordance with the subject invention.
  • FIG. 2 is a cross-sectional view taken along line 2 - 2 in FIG. 1.
  • FIG. 3 is a cross-sectional view similar to FIG. 2, but showing an alternate package.
  • a package in accordance with the subject invention is identified generally by the numeral 10 in FIGS. 1 and 2.
  • Package 10 contains a tube 12 formed from a plastic material, such as polyethylene terephthalate (PET) or polypropylene.
  • Tube 12 includes a closed bottom 14 , an open top 16 , and a cylindrical side wall 18 extending therebetween.
  • a liquid 20 is disposed in tube 12 as shown in FIG. 2.
  • Liquid 20 may be a liquid additive of a specified volume, concentration and solubility that is intended for mixing with a non-liquid drug and for subsequent administration to a patient.
  • liquid 20 may be a liquid drug.
  • Closure 22 comprises a thermoplastic elastomer or a thermoset resin material that is sufficiently deformable and resilient for secure sealing engagement with side wall 18 of tube 12 .
  • Closure 22 may further include a more rigid plastic structure to which the thermoplastic elastomer or thermoset resin is secured to enable closure 22 to be placed in and removed from tube 12 with ease.
  • the plastic material of tube 12 is inherently permeable to water. Water vapor permeation through the plastic of tube 12 has the potential for affecting the volume, concentration or solubility of liquid additive 20 stored in tube 12 .
  • package 10 comprises a high moisture barrier film 26 that completely and relatively closely surrounds tube 12 .
  • Film 26 may be a foil lamination comprising a substrate formed from a metallic foil, such as aluminum, and at least one layer formed from a plastic material that is readily sealable.
  • the foil lamination may include an outer layer that is well suited to printing indicia to identify the specific liquid additive in tube 12 .
  • Film 26 alternatively may be a metalized polyester, a SiOx coated polyester, a polyester-polyoefilin or PVDC, all of which are substantially impermeable to water, particularly in comparison to the PET or polypropylene from which tube 12 is formed.
  • Film 26 of package 10 may define an envelope formed from a single sheet that is folded at fold region 28 to closely surround tube 12 . Adjacent registered edges 30 may be bonded in face-to-face relationship as shown in FIG. 2.
  • package 10 may be formed from two separate sheets of film 26 a and 26 b as shown in FIG. 3. Sheets 26 a and 26 b may originally be in strip form. Tube 12 with liquid 20 therein may be placed on a lower sheet of film 26 a, which may be part of a strip moving longitudinally along a conveying apparatus. Upper sheet of film 26 b may be part of a second strip that is fed into juxtaposed relationship to the strip defining lower sheet of film 26 a.
  • the lower and upper sheets 26 a and 26 b may be sealed along opposed side edges 30 a, and may subsequently be sealed and cut between adjacent tubes to form seals 32 .
  • the lower and upper sheets of film 26 a and 26 b may be formed from different materials.
  • a lower sheet of film 26 a may be a foil lamination having an only upper layer of a plastic material that will bond well with a lower plastic layer on upper sheet 26 b.
  • Upper sheet 26 b may also include an upper laminated layer that is well suited to receiving printed indicia.

Abstract

A packaged liquid-filled plastic tube is provided to achieve a desirably long shelf life. The tube is formed from PET, polypropylene or otherknown plastics that exhibit high liquid permeability. A liquid additive of a specified volume, concentration and/or solubility is placed in the tube and the tube is sealed. Loss of liquid through the permeable tube is prevented by a moisture barrier film that is sealed around the tube. The moisture barrier film maintains a high relative humidity adjacent said tube and substantially minimizes transport of liquid vapor through the plastic of the tube.

Description

    RELATED APPLICATION
  • This application is a non-provisional application of U.S. Provisional Patent Appl. No. 60/376,149 filed Apr. 26, 2002.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The subject invention relates to plastic tubes that have been prefilled with controlled volumes and concentrations of liquid, and that are packaged to retain the liquid volume and concentration during storage. [0003]
  • 2. Description of the Prior Art [0004]
  • Many medical procedures require a specified dose of a drug to be administered to a patient. Drugs that are administered intravenously must be in a liquid form. The liquid must be of known volume and concentration to ensure proper dosage. [0005]
  • Some drugs can be stored for considerable periods of time in a liquid form. Other drugs, however, must be stored in a powdered form, and then must be mixed with a specified volume of a liquid additive shortly prior to administration to the patient. Efficiencies can be achieved if the specified volume of the liquid drug and/or the specified volume of the liquid additive is available in a prefilled tube or other such container. Prefilled containers avoid the need for careful volummetric measuring immediately prior to administering the drug, and hence minimize the chance for error. [0006]
  • Plastic tubes and other plastic containers are lightweight, relatively inexpensive and relatively unbreakable. As a result, plastic tubes are used for medical applications whenever possible. However, plastic tubes have an inherent permeability to water and other liquids. This high liquid permeability of plastics can significantly affect the volume, concentration and solubility of liquids that are stored for a long period of time in a plastic container. Containers filled with a liquid drug or with a liquid additive for a powdered drug desirably should have a relatively long shelf life. As a result, plastic containers are considered unacceptable for long term storage of liquid drugs or liquid additives for drugs. [0007]
  • Glass is substantially impermeable to water and other liquids. As a result, liquid drugs or liquid additives for drugs typically are stored in glass tubes or other glass containers. However, glass is much more breakable than plastic. A glass tube can be broken easily while the tube is being manipulated to access the liquid stored therein. Additionally, a small round glass tube can be dropped inadvertently and shattered inadvertently. Sharp edges of a broken glass tube can cut a patient or health care worker, and may create an open wound that can lead to disease transmission. Fragile glass containers also require protective packaging that typically increases storage space requirements and that may add to costs. [0008]
  • The prior art has included attempts to minimize or offset the loss of liquid from plastic tubes. For example, one prior art attempt has bulk packaged a plurality of plastic tubes in a plastic tub. A moisture source also has been placed in the tub to provide a higher vapor content surrounding the bulk packaged tubes, and thereby to impede the outflow of liquid from the tubes. This prior art bulk packaging complicates the packaging process and adds to cost and storage space requirements. Furthermore, vapor from the moisture source is transported through the permeable walls of the plastic tub. [0009]
  • The prior art also includes tubes that are laminated with foil to prevent liquid loss. Foil lamination of tubes adds significantly to the tube manufacturing complexity and adds to tube manufacturing cost. [0010]
  • SUMMARY OF THE INVENTION
  • The subject invention is directed to a plastic container in which a liquid drug or a liquid additive solution for a drug has been placed. The plastic container may be formed from a known plastic material, such as polyethylene terephthalate (PET), polypropylene or other plastic material that exhibits liquid permeability. The container may be a tube of prior art construction, and may include a closed bottom, an open top and a continuous side wall extending therebetween. A closure may be securely mounted to the container for closing the open top, and thereby preventing spillage of the liquid drug or the liquid additive stored in the container. [0011]
  • The subject invention further includes packaging formed from a high moisture barrier material that completely surrounds the container or that completely surrounds a plurality of such containers. The high moisture barrier material may be a film formed from a foil lamination, a metalized polyester, SiOx coated polyesters, polyester-polyoefilins, PVDC or the like. This high moisture barrier material may be a sheet folded around one or more plastic containers of a liquid drug or liquid additive. Edge regions of the sheet then may be sealed in face-to-face engagement with other areas on the sheet. Alternatively a container may be placed between two sheets of high moisture barrier material, and edge regions of the sheets may be sealed. The high moisture barrier packaging material can impede the rate of water vapor transport across the plastic material from which the container is formed by providing and maintaining a high relative humidity environment around the container and inside the package. This enables the volume, concentration and solubility of the liquid in the container to be controlled, and enables a longer shelf life for the liquid therein.[0012]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a top plan view of a liquid-containing plastic tube packaged in accordance with the subject invention. [0013]
  • FIG. 2 is a cross-sectional view taken along line [0014] 2-2 in FIG. 1.
  • FIG. 3 is a cross-sectional view similar to FIG. 2, but showing an alternate package.[0015]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • A package in accordance with the subject invention is identified generally by the [0016] numeral 10 in FIGS. 1 and 2. Package 10 contains a tube 12 formed from a plastic material, such as polyethylene terephthalate (PET) or polypropylene. Tube 12 includes a closed bottom 14, an open top 16, and a cylindrical side wall 18 extending therebetween. A liquid 20 is disposed in tube 12 as shown in FIG. 2. Liquid 20 may be a liquid additive of a specified volume, concentration and solubility that is intended for mixing with a non-liquid drug and for subsequent administration to a patient. Alternatively, liquid 20 may be a liquid drug.
  • Liquid [0017] 20 is sealingly retained in tube 12 by a closure 22. Closure 22 comprises a thermoplastic elastomer or a thermoset resin material that is sufficiently deformable and resilient for secure sealing engagement with side wall 18 of tube 12. Closure 22 may further include a more rigid plastic structure to which the thermoplastic elastomer or thermoset resin is secured to enable closure 22 to be placed in and removed from tube 12 with ease.
  • The plastic material of [0018] tube 12 is inherently permeable to water. Water vapor permeation through the plastic of tube 12 has the potential for affecting the volume, concentration or solubility of liquid additive 20 stored in tube 12. To substantially minimize vapor transport through the plastic of tube 12, package 10 comprises a high moisture barrier film 26 that completely and relatively closely surrounds tube 12. Film 26 may be a foil lamination comprising a substrate formed from a metallic foil, such as aluminum, and at least one layer formed from a plastic material that is readily sealable. The foil lamination may include an outer layer that is well suited to printing indicia to identify the specific liquid additive in tube 12. Film 26 alternatively may be a metalized polyester, a SiOx coated polyester, a polyester-polyoefilin or PVDC, all of which are substantially impermeable to water, particularly in comparison to the PET or polypropylene from which tube 12 is formed.
  • [0019] Film 26 of package 10 may define an envelope formed from a single sheet that is folded at fold region 28 to closely surround tube 12. Adjacent registered edges 30 may be bonded in face-to-face relationship as shown in FIG. 2. Alternatively, package 10 may be formed from two separate sheets of film 26 a and 26 b as shown in FIG. 3. Sheets 26 a and 26 b may originally be in strip form. Tube 12 with liquid 20 therein may be placed on a lower sheet of film 26 a, which may be part of a strip moving longitudinally along a conveying apparatus. Upper sheet of film 26 b may be part of a second strip that is fed into juxtaposed relationship to the strip defining lower sheet of film 26 a. The lower and upper sheets 26 a and 26 b may be sealed along opposed side edges 30a, and may subsequently be sealed and cut between adjacent tubes to form seals 32. In this embodiment, the lower and upper sheets of film 26 a and 26 b may be formed from different materials. For example, a lower sheet of film 26 a may be a foil lamination having an only upper layer of a plastic material that will bond well with a lower plastic layer on upper sheet 26 b. Upper sheet 26 b, however, may also include an upper laminated layer that is well suited to receiving printed indicia.

Claims (15)

What is claimed is:
1. Packaging for liquids of specified volume, concentration and solubility, said packaging comprising:
at least one plastic container having a closed bottom, an open top and a side wall extending therebetween, said liquid of said specified volume, concentration and solubility being placed in said container, a closure sealingly engaged with said open top of said container for retaining said liquid therein, a moisture barrier film completely surrounding said container for preventing vapor transport across said film and maintaining a selected relative humidity between said container and said film for substantially preventing permeation of said liquid from said container.
2. The packaging of claim 1, wherein said container is formed from polyethylene terephthalate.
3. The packaging of claim 1, wherein said container is formed from polypropylene.
4. The packaging of claim 1, wherein said film is selected from the group consisting of foil laminations, metalized polyesters, SiOx coated polyesters, polyester-polyoefilins and PVDC.
5. The packaging of claim 1, comprising a single sheet of said film folded around said container, registered edges of said sheet being secured to one another.
6. The packaging of claim 1, comprising first and second sheets of said film having registered edges secured in face-to-face relationship with one another entirely around said container.
7. The packaging of claim 1, wherein said container is a tube.
8. A method for packaging liquids to maintain a specified volume, concentration and solubility, said method comprising:
providing a plastic container having a closed bottom, an open top and a side wall extending therebetween;
depositing in said plastic container said liquid of said specified volume, concentration and solubility;
sealingly enganging a closure with said open top of said container for retaining said liquid therein;
providing a moisture barrier film completely around said plastic container and said closure for preventing vapor transport across said film and maintaining a selected relative humidity between said container and said film for substantially preventing permeation of said liquid from said container.
9. The method of claim 8, wherein said step of providing a container comprises providing a container formed from polyethylene terephthalate.
10. The method of claim 8, wherein step of providing a container comprises providing a container formed from polypropyelene.
11. The method of claim 8, wherein said step of providing a moisture barrier film comprises providing a moisture barrier film selected from the group consisting of foil laminations, metalized polyesters, SiOx coated polyesters, polyester-polyoefilins and PVDC.
12. The method of claim 8, wherein said step of completely surrounding said container with a moisture barrier film comprises folding a single sheet of said film around said container such that edges of said single sheet are substantially registered with one another and securing opposed faces of said sheet to one another adjacent said registered edges.
13. The method of claim 8, wherein said step of completely surrounding said container with the moisture barrier film comprises placing said container between first and second sheets of said moisture barrier film and securing opposed faces of said first and second sheets to one another.
14. The method of claim 8, wherein said step of sealingly engaging a closure with said open top of said container comprises providing a closure formed from a thermoplastic elastomer and urging said closure into said open top of said container such that said thermoplastic elastomer sealingly engages said side wall of said container adjacent said open top.
15. The method of claim 8, wherein said step of sealingly engaging a closure with said open top of said container comprises providing a closure formed from a thermoset resin and urging said closure into said open top of said container such that said thermoplastic elastomer sealingly engages said side wall of said container adjacent said open top.
US10/271,107 2002-04-26 2002-10-11 Collection assembly Abandoned US20030200727A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/271,107 US20030200727A1 (en) 2002-04-26 2002-10-11 Collection assembly

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37614902P 2002-04-26 2002-04-26
US10/271,107 US20030200727A1 (en) 2002-04-26 2002-10-11 Collection assembly

Publications (1)

Publication Number Publication Date
US20030200727A1 true US20030200727A1 (en) 2003-10-30

Family

ID=29215903

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/271,107 Abandoned US20030200727A1 (en) 2002-04-26 2002-10-11 Collection assembly

Country Status (2)

Country Link
US (1) US20030200727A1 (en)
EP (1) EP1358938A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10709866B2 (en) 2014-05-13 2020-07-14 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US10828482B2 (en) 2013-12-20 2020-11-10 Fisher & Paykel Healthcare Limited Humidification system connections
US10974015B2 (en) 2012-03-15 2021-04-13 Fisher & Paykel Healthcare Limited Respiratory gas humidification system
US11129956B2 (en) 2012-04-27 2021-09-28 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US11173272B2 (en) 2014-05-02 2021-11-16 Fisher & Paykel Healthcare Limited Gas humidification arrangement
US11278689B2 (en) 2014-11-17 2022-03-22 Fisher & Paykel Healthcare Limited Humidification of respiratory gases
US11324911B2 (en) 2014-06-03 2022-05-10 Fisher & Paykel Healthcare Limited Flow mixers for respiratory therapy systems
US11351332B2 (en) 2016-12-07 2022-06-07 Fisher & Paykel Healthcare Limited Sensing arrangements for medical devices
US11511069B2 (en) 2013-09-13 2022-11-29 Fisher & Paykel Healthcare Limited Humidification system
US11559653B2 (en) 2014-02-07 2023-01-24 Fisher & Paykel Healthcare Limited Respiratory humidification system
US11801360B2 (en) 2013-09-13 2023-10-31 Fisher & Paykel Healthcare Limited Connections for humidification system

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2283867A (en) * 1939-12-19 1942-05-19 Stokes Machine Co Packaging and preserving dried biologicals, pharmaceuticals, and the like
US4038148A (en) * 1975-12-22 1977-07-26 Marion Laboratories, Inc. Anaerobic environmental system for bacteria culture testing
US4108309A (en) * 1976-10-15 1978-08-22 All One God Faith, Inc. Contraceptive containing device
US4927010A (en) * 1988-12-27 1990-05-22 Sealed Air Corporation Shipping bag for containers of potentially biohazardous liquids
US4942966A (en) * 1989-06-05 1990-07-24 Kemp David R Containment device for a test tube
US5647480A (en) * 1995-01-27 1997-07-15 Minnesota Mining And Manufacturing Company Flexible pressure vessels for and method of transporting hazardous materials
US6050400A (en) * 1994-06-10 2000-04-18 Smithkline Beecham Plc Package
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
US6161687A (en) * 1999-02-10 2000-12-19 Technicor, Inc. Vial container
US6179118B1 (en) * 1998-12-18 2001-01-30 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6308827B1 (en) * 1999-02-10 2001-10-30 Technicor Inc. Labeling system for vial container

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520443B1 (en) * 1991-06-26 1997-01-08 Ppg Industries, Inc. Electrochemical sensor assembly
US5738920A (en) * 1996-01-30 1998-04-14 Becton, Dickinson And Company Blood collection tube assembly
JP2001521785A (en) * 1997-10-31 2001-11-13 アボット・ラボラトリーズ System for storing an oxygen sensitive composition

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2283867A (en) * 1939-12-19 1942-05-19 Stokes Machine Co Packaging and preserving dried biologicals, pharmaceuticals, and the like
US4038148A (en) * 1975-12-22 1977-07-26 Marion Laboratories, Inc. Anaerobic environmental system for bacteria culture testing
US4108309A (en) * 1976-10-15 1978-08-22 All One God Faith, Inc. Contraceptive containing device
US4927010A (en) * 1988-12-27 1990-05-22 Sealed Air Corporation Shipping bag for containers of potentially biohazardous liquids
US4942966A (en) * 1989-06-05 1990-07-24 Kemp David R Containment device for a test tube
US6050400A (en) * 1994-06-10 2000-04-18 Smithkline Beecham Plc Package
US5647480A (en) * 1995-01-27 1997-07-15 Minnesota Mining And Manufacturing Company Flexible pressure vessels for and method of transporting hazardous materials
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
US6179118B1 (en) * 1998-12-18 2001-01-30 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6161687A (en) * 1999-02-10 2000-12-19 Technicor, Inc. Vial container
US6308827B1 (en) * 1999-02-10 2001-10-30 Technicor Inc. Labeling system for vial container

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10974015B2 (en) 2012-03-15 2021-04-13 Fisher & Paykel Healthcare Limited Respiratory gas humidification system
US11129956B2 (en) 2012-04-27 2021-09-28 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US11878093B2 (en) 2012-04-27 2024-01-23 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US11511069B2 (en) 2013-09-13 2022-11-29 Fisher & Paykel Healthcare Limited Humidification system
US11801360B2 (en) 2013-09-13 2023-10-31 Fisher & Paykel Healthcare Limited Connections for humidification system
US10828482B2 (en) 2013-12-20 2020-11-10 Fisher & Paykel Healthcare Limited Humidification system connections
US11826538B2 (en) 2013-12-20 2023-11-28 Fisher & Paykel Healthcare Limited Humidification system connections
US11559653B2 (en) 2014-02-07 2023-01-24 Fisher & Paykel Healthcare Limited Respiratory humidification system
US11173272B2 (en) 2014-05-02 2021-11-16 Fisher & Paykel Healthcare Limited Gas humidification arrangement
US10709866B2 (en) 2014-05-13 2020-07-14 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US11712536B2 (en) 2014-06-03 2023-08-01 Fisher & Paykel Healthcare Limited Flow mixers for respiratory therapy systems
US11324911B2 (en) 2014-06-03 2022-05-10 Fisher & Paykel Healthcare Limited Flow mixers for respiratory therapy systems
US11278689B2 (en) 2014-11-17 2022-03-22 Fisher & Paykel Healthcare Limited Humidification of respiratory gases
US11351332B2 (en) 2016-12-07 2022-06-07 Fisher & Paykel Healthcare Limited Sensing arrangements for medical devices

Also Published As

Publication number Publication date
EP1358938A1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
US11452811B2 (en) Application arrangement with a medicinal substance fluid
RU2103987C1 (en) Multiple-chamber vessel
EP1520574B1 (en) Flexible medical container packaging
KR100209830B1 (en) Vessel having a plurality of chambers
US20170008686A1 (en) Packaged medicine-filled container
JP2007020710A (en) Medical container packing body
JPH08257102A (en) Double-chamber container
US20030200727A1 (en) Collection assembly
CN114206294A (en) Packaged medical device
KR20090115146A (en) Multi-chamber bag
US20040118859A1 (en) Fluid container pouch
JPH0639713Y2 (en) Infusion bag
JP4335334B2 (en) Drug infusion container
CN212922712U (en) Combined package
JP4385689B2 (en) Laminate with suppressed generation of pinholes and infusion bag package using the laminate
JP2008132100A (en) Packaging bag for liquid bag and liquid bag package
JP2005096792A (en) Laminated packaging material and laminated packaging bag, which suppress formation of pinhole
JP2000084046A (en) Composite infusion solution container
JPS6278061A (en) Packaging bag
JPH0652832U (en) Packaging bag and package for chemical solution filling bag
JPH10338275A (en) Packaging member for medical container
JPH08150678A (en) Laminated sheet and container using it
JPH07116306B2 (en) Medical liquid packaging material
MXPA06004065A (en) Fluid container pouch
JPH10297679A (en) Packaging body

Legal Events

Date Code Title Description
AS Assignment

Owner name: BECTON, DICKINSON AND COMPANY, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KIM, YONG JAE;REEL/FRAME:013810/0983

Effective date: 20030222

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION